Former Cy Young winner takes powerful drug to aid his performance, no one cares

57 Comments

What if I were to tell you that there was a former Cy Young winner who was taking a controversial and powerful drug?

A drug that could prove dangerous to him in the long run and has been linked to organ damage? A drug that other players who have used it say gives them a feeling of invulnerability? A drug that experts are wary of for athletes because its long term effects when taken regularly aren’t known? A drug that is injected into the buttocks. A drug that, despite all of this, the player uses because it helps him recover from injury, soreness and fatigue and helps him get back on the field?

Why, I hope you would say nothing, because as David Lennon of Newsday reports, it’s totally OK in Major League Baseball:

When Johan Santana said last week that he received an injection of Toradol, a powerful anti-inflammatory medication, to stay on schedule for his Opening Day start, it hardly raised eyebrows in the clubhouse.

The reason? Santana is not the only one to benefit from the drug, and its use is more common than people might think.

There is not some logical bright line between what is a horrible, terrible PED and what is an acceptable drug in the world of sports. We like to pretend there is, but really, there isn’t. The biggest difference is that some are on a banned list and some are not, and that Santana and others use Toradol under a physicians care and guys who take banned drugs don’t.

Ultimately, these drugs are allowing players to do what their body would not naturally allow them to do. Here, it’s ignoring pain that could keep them from playing or certainly playing well.  With other drugs, it’s recovering from injury faster (HGH) or hitting a ball farther than they otherwise might (steroids). Either way, their performance is enhanced. Their natural state is altered by pharmaceuticals.

It would be awesome if we could approach some of the banned PEDs in this way and determine whether they present acceptable risks. Whether they serve a valuable purpose that, under a doctor’s care, don’t raise serious ethical concerns.  But we just don’t roll that way in professional sports these days.

Report: The White Sox and Diamondbacks are in on Manny Machado

Getty Images
Leave a comment

Buster Olney of ESPN reports that the White Sox and Diamondbacks have emerged as two of the strongest contenders for Orioles third baseman Manny Machado. It seems like a foregone conclusion that Baltimore will deal their superstar infielder this winter, but nothing appears imminent just yet. While both the White Sox and D-backs have reportedly made serious offers, Orioles owner Peter Angelos is wary of any non-contending team that might be incentivized to flip Machado to the rival Yankees next season.

The White Sox, for their part, have assured the Orioles that they view Machado more as a solid one-year rental than the new face of their franchise, with no immediate plans to deal him elsewhere. Given their current rebuilding status and the unlikelihood that they would contend in 2018, it makes their offer a bit of a head-scratcher — and, as USA Today Sports’ Bob Nightengale points out, they’ve been reluctant to put any top-5 prospects on the table in preliminary negotiations.

The Diamondbacks, on the other hand, are far better positioned to enter the postseason in 2018, though that doesn’t automatically make them the perfect landing spot for Machado. They already have Jake Lamb stationed at third base, and while it’s not inconceivable that they could jettison the Ketel Marte/Chris Owings/Nick Ahmed shortstop platoon for someone of Machado’s talent, his $17 million salary appears to be more than the D-backs are currently capable of absorbing.

The White Sox and D-backs may have exhibited the most interest in Machado so far, but they’re hardly the only contenders here. MASN Sports’ Roch Kubatko maintains that the Cardinals and Yankees remain in discussions for the 25-year-old, with Cardinals’ RHP Jordan Hicks and catcher Carson Kelly drawing interest, as well as Yankees’ top prospect Gleyber Torres. Any deal involving the Yankees still feels like a long shot, however; as Craig mentioned on Wednesday, it makes sense that the club wouldn’t want to see their star player hanging around their division rivals in 2018, and the Yankees should be well prepared to make a run at him in free agency next winter.